Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifeonics is a New Zealand private company developing and commercializing analytical instrumentation for microbiology and cell-culture monitoring. Its flagship product, SMOD, is a wireless bio-photometer that measures real-time optical density (OD600) and temperature in microbial and suspension cell cultures. The company appears to focus on research and bioprocess workflows rather than therapeutics, serving laboratories working with bacteria and yeast for applications such as plasmid production and recombinant protein development. Lifeonics combines biotechnology, microbiology, electronics, and sensor engineering to improve productivity and quality in laboratory culture monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifeonics.